Study S001660

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06725693
Study type: OBSERVATIONAL
Status: RECRUITING
Enrollment: 500
Start: 2019-02-01
Primary completion: 2027-11-01
Lead sponsor: Tianjin Medical University
Conditions: GLP1-R-related Disease; Tumor; Insulinoma; Positron Emission Tomography
Interventions: DIAGNOSTIC_TEST:18F/68Ga-Exendin 4
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Standardized uptake value (SUV) [30 days]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0015068	Comparison of PET/CT using 68Ga-NOTA-Exendin-4 with 68Ga-DOTATATE, 18F-FDG, and conventional imaging in the localization of insulinomas. Yu H, European journal of nuclear medicine and molecular imaging	2025	Nonrandomized study	PMID 40259061 DOI	cites ClinicalTrials.gov:NCT06725693; registry reference DERIVED:40259061